Recently, extraordinary progress has been made in our understanding of the mechanisms and molecular pathways underlying focal and sclerotic bone diseases, rare disorders which have a strong genetic ...
-- GFB-887, company’s lead precision kidney medicine product candidate, is a highly potent and selective inhibitor of the TRPC5-Rac1 pathway -- -- TRPC5-Rac1 pathway overactivation is key cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results